Suchergebnisse - "Zhu, Doreen"

PubPharm (11)

1

Improvements in Kidney Outcomes Over the Years : Reason for Optimism but a Challenge for Trialists

enthalten in: American journal of kidney diseases : the official journal of the National Kidney Foundation | 2024

von Zhu, D. | Judge, P. | Haynes, R.

2

Effects of Empagliflozin on Fluid Overload, Weight, and Blood Pressure in CKD

enthalten in: Journal of the American Society of Nephrology : JASN | 2024

von Mayne, K. | Staplin, N. | Keane, D. | +128

3

Interference of urinary albumin-to-creatinine ratio measurement by glycosuria : clinical implications when using SGLT-2 inhibitors

enthalten in: Kidney international | 2023

von Chapman, D. | Judge, P. | Sardell, R. | +11

CommentIn: Kidney Int. 2023 Jul;104(1):201. - PMID 37349050

4

Empagliflozin in Patients with Chronic Kidney Disease

enthalten in: The New England journal of medicine | 2023

von The EMPA-KIDNEY Collaborative Group | Herrington, W. | Staplin, N. | +137

CommentIn: Nat Rev Nephrol. 2023 Jan;19(1):3. - PMID 36450917

5

Determining the Relationship Between Blood Pressure, Kidney Function, and Chronic Kidney Disease : Insights From Genetic Epidemiology

enthalten in: Hypertension (Dallas, Tex. : 1979) | 2022

von Staplin, N. | Herrington, W. | Murgia, F. | +11

CommentIn: Hypertension. 2022 Dec;79(12):2682-2684. - PMID 36350775

6

Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes : collaborative meta-analysis of large placebo-controlled trials

enthalten in: Lancet (London, England) | 2022

von Nuffield Department of Population Health Renal Studies Group | SGLT2 inhibitor Meta-Analysis Cardio-Renal Trialists' Consortium | Baigent, C. | +39

CommentIn: Lancet. 2022 Nov 19;400(10365):1745-1747. - PMID 36351457

7

Design, recruitment, and baseline characteristics of the EMPA-KIDNEY trial

enthalten in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association | 2022

von EMPA-KIDNEY Collaborative Group | Herrington, W. | Wanner, C. | +98

8

Improving the diagnostic pathway in patients presenting with acute kidney injury secondary to de novo multiple myeloma : a short report

enthalten in: BMJ open quality | 2021

von Rana, R. | Pratt, G. | Cook, M. | +6

9

Chronic kidney disease, heart failure and neprilysin inhibition

enthalten in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association | 2020

von Haynes, R. | Zhu, D. | Judge, P. | +3

10

In type 2 diabetes, SGLT-2 inhibitors reduce risk for major kidney outcomes

enthalten in: Annals of internal medicine | 2020

von Ai Ng, S. | Zhu, D. | Herrington, W.

CommentOn: Lancet Diabetes Endocrinol. 2019 Nov;7(11):845-854. - PMID 31495651